Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells

Journal of Cancer Research and Clinical Oncology
C-Q SuQ-J Qian

Abstract

Telomerase reverse transcriptase (hTERT) is the key determinant of telomerase activity and plays a crucial role in cellular immortalization and oncogenesis. It will be a promising target for cancer gene therapy. We constructed a novel replicative adenovirus CNHK300 in which hTERT promoter with three extra E-boxes downstream of the promoter was introduced and used to regulate adenoviral E1a gene, and studied its properties of selective replication in cancer cells and antitumoral activity. Luciferase assay was used to detect hTERT promoter activity. The selective replication of CNHK300 in cancer cells was investigated by E1a Western blot and green fluorescent protein (GFP) reporter gene assay. The antitumoral activity of CNHK300 and its toxicity were measured on animal models. Luciferase assay showed that introducing extra E-boxes downstream of hTERT promoter is beneficial to decreasing the promoter activity in normal cells without affecting its strong activity in cancer cells. Experiments in vitro and in vivo demonstrated that CNHK300 can selectively target to hTERT-positive cancer cells and replicate in them, resulting in oncolytic or antitumoral effect. CNHK300 is superior to ONYX-015 in terms of selective replication and onco...Continue Reading

Citations

Jun 25, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·S BortolanzaR Hernandez-Alcoceba
Jun 25, 2009·Apoptosis : an International Journal on Programmed Cell Death·Min XieGuo-Rui Ruan
Feb 7, 2009·Cancer Gene Therapy·J J Cody, J T Douglas
Feb 27, 2008·World Journal of Gastroenterology : WJG·Yue-Min LiQi-Jun Qian
Apr 28, 2009·Advanced Drug Delivery Reviews·Dominik E Dorer, Dirk M Nettelbeck
Feb 14, 2006·Critical Reviews in Oncology/hematology·Ken André OlaussenJean-Charles Soria
Apr 13, 2015·Current Opinion in Virology·Autumn J Ruiz, Stephen J Russell
Aug 16, 2008·Toxicological Sciences : an Official Journal of the Society of Toxicology·Changqing SuQijun Qian

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.